Optigenex (OPGX) Stock Analysis & Winston Score

Optigenex Inc. is a small healthcare company focused on medical diagnostics and research. It works on developing products and technologies related to biological testing and analysis, targeting customers in the healthcare and life sciences space. The company operates in a highly competitive segment of the healthcare industry where many firms are working to bring new diagnostic tools to market.

Optigenex generates revenue through its research and development activities, though its negative gross margin of -22.1% signals it currently spends more to deliver its products or services than it earns from them. The company is very small, with a market cap near zero, suggesting it is in an early stage of building its business. The main risk facing Optigenex is its ability to secure enough funding and generate sustainable revenue before its resources run out, which is a common challenge for micro-cap healthcare companies that have not yet reached profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+98.4% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

EPS data limited

Insider Activity

1.6%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$21,398 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Revenue accelerating

Optigenex grew revenue 98% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

65.1%

Premium pricing power — 65.1% gross margin

Operating Margin

107.4%

Excellent — 107.4% operating margin

ROCE

17.1%

Strong — 17.1% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+64.0%

Fast-growing sales (64.0% YoY)

EPS YoY

N/A

—

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-27.8%

Burning cash (-27.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

0.56x

Dangerous — barely covers interest (0.6x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial